Crossmark Global Holdings’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$267K Sell
3,580
-2,274
-39% -$170K ﹤0.01% 1152
2025
Q1
$372K Sell
5,854
-30
-0.5% -$1.91K 0.01% 987
2024
Q4
$459K Sell
5,884
-630
-10% -$49.1K 0.01% 867
2024
Q3
$524K Sell
6,514
-3,484
-35% -$280K 0.01% 844
2024
Q2
$827K Buy
9,998
+2,370
+31% +$196K 0.02% 646
2024
Q1
$651K Buy
7,628
+4,002
+110% +$342K 0.01% 756
2023
Q4
$310K Sell
3,626
-393
-10% -$33.6K 0.01% 1056
2023
Q3
$372K Sell
4,019
-41
-1% -$3.8K 0.01% 922
2023
Q2
$377K Sell
4,060
-276
-6% -$25.6K 0.01% 960
2023
Q1
$358K Buy
4,336
+148
+4% +$12.2K 0.01% 970
2022
Q4
$330K Buy
4,188
+83
+2% +$6.54K 0.01% 980
2022
Q3
$304K Sell
4,105
-305
-7% -$22.6K 0.01% 986
2022
Q2
$287K Sell
4,410
-10
-0.2% -$651 0.01% 1048
2022
Q1
$279K Buy
4,420
+10
+0.2% +$631 0.01% 1173
2021
Q4
$234K Buy
4,410
+510
+13% +$27.1K 0.01% 1276
2021
Q3
$275K Sell
3,900
-20
-0.5% -$1.41K 0.01% 1206
2021
Q2
$261K Sell
3,920
-450
-10% -$30K 0.01% 1253
2021
Q1
$485K Sell
4,370
-20
-0.5% -$2.22K 0.01% 917
2020
Q4
$521K Sell
4,390
-130
-3% -$15.4K 0.01% 830
2020
Q3
$394K Sell
4,520
-130
-3% -$11.3K 0.01% 880
2020
Q2
$416K Buy
4,650
+470
+11% +$42K 0.01% 837
2020
Q1
$417K Sell
4,180
-70
-2% -$6.98K 0.01% 710
2019
Q4
$488K Sell
4,250
-780
-16% -$89.6K 0.01% 810
2019
Q3
$634K Sell
5,030
-250
-5% -$31.5K 0.02% 695
2019
Q2
$635K Sell
5,280
-359
-6% -$43.2K 0.02% 702
2019
Q1
$493K Buy
5,639
+90
+2% +$7.87K 0.01% 816
2018
Q4
$555K Buy
5,549
+930
+20% +$93K 0.02% 728
2018
Q3
$529K Sell
4,619
-60
-1% -$6.87K 0.01% 919
2018
Q2
$420K Sell
4,679
-3,450
-42% -$310K 0.01% 1075
2018
Q1
$595K Sell
8,129
-1,949
-19% -$143K 0.02% 818
2017
Q4
$585K Buy
10,078
+229
+2% +$13.3K 0.01% 879
2017
Q3
$442K Buy
+9,849
New +$442K 0.01% 1037
2016
Q3
$442K Buy
+9,849
New +$442K 0.01% 1037